Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Gbp Regulatory News (CVCG)

Share Price Information for Cvc Ig Gbp (CVCG)

Share Price is delayed by 15 minutes
Get Live Data
115.50    -0.50 (-0.43%)
Bid:
115.50
Ask:
116.00
Spread: 0.50 (0.433%)
Market Cap: £320.57m
CVCG Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Gbp Share Chart

Share Price Movement Update

17 Mar 2026 15:42

RNS Number : 0171X
CVC Income & Growth Limited
17 March 2026
 

17 March 2026

 

CVC Income & Growth Limited

(the Company)

 

Share Price Movement Update

 

The Board of the Company notes the recent share price movements in the Sterling and Euro share classes since the beginning of 2026 and provides the following update.

The Company's Sterling and Euro share price has fallen by more than 8% (as at close of trading on 16 March 2026). This decrease in share price is significantly more than the UBS European Leveraged Loan index which has fallen by 0.81% Year to Date (YTD) and Bloomberg European Leveraged Loan index which has fallen 0.98% YTD. The Board and the Investment Vehicle Manager consider it is reasonable to believe that the underlying portfolio's performance should broadly track the indices.

 

Publicly traded corporate credit versus private credit

The Company provides exposure primarily to publicly traded corporate credit, including syndicated loans and bonds. These assets differ from private credit investments in that they are actively traded in secondary markets and priced daily, rather than typically being priced quarterly which is the case for private credit.

Circa 98% of the loans and bonds within the underlying portfolio are priced daily based on traded broker marks. The Company's shares trade intraday on the London Stock Exchange, providing shareholders with daily secondary market liquidity.

 

Interest rate environment

Recent geopolitical developments and energy market volatility have contributed to increased uncertainty regarding the outlook for inflation and the path of interest rates during 2026. At the beginning of the year, the market had anticipated a series of interest rate reductions from the Bank of England, while the European Central Bank was expected to hold interest rates flat. However, renewed inflationary pressures, driven by energy markets, renewed supply chain issues and geopolitical developments, have contributed to a reassessment of the trajectory for interest rates in both geographies.

The Company's strategy focuses on floating-rate credit instruments, primarily senior secured loans. As a result, the income generated by the underlying portfolio is linked to prevailing base rates. In an environment where the pace of rate reductions is slower than previously anticipated, the portfolio's floating-rate characteristics may support the level of income generated by the underlying assets, subject to broader market conditions and portfolio performance.

 

Exposure to the software sector

Recent media coverage has highlighted concerns around sector concentration in software lending, which in some credit portfolios can represent a significant proportion of assets.

The Company has an exposure of circa 3% to software companies.

The Company's Investment Vehicle Manager notes: "The outlook for 2026 was fairly benign at the start of the year, which was reflected in credit spreads. Since then, markets have repriced software risk in both public equity and public credit markets given the fast-paced developments we've seen in AI. After the recent developments in the Middle East, markets have also started to price in higher for longer oil prices which could result in a slowdown in growth, but also higher inflation, potential supply chain issues and a reduction in consumer confidence. At this point, it's impossible to say where the conflict is heading. The portfolio continues to generate income in line with expectations, but the marks on the underlying assets move on a daily basis reflecting sentiment around the conflict and global growth. Both public equity and credit markets have repriced since the start of the year, resulting in a small negative NAV performance YTD. This shows that public credit markets are functioning."

 

--- END ---

 

Enquiries:

Cadarn Capital

Email: info@cadarncapital.com

 

BNP Paribas S.A. Jersey Branch

Email: cvccpeolcosec@bnpparibas.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDZGMFKNGGVZM
Date   Source Headline
28th Jan 20263:48 pmRNSPublication of Monthly Report
27th Jan 202611:21 amRNSJANUARY 2026 SHARE CONVERSION
27th Jan 20269:30 amRNSNet Asset Value Month End 31 Dec 2025
26th Jan 20263:48 pmRNSDIVIDEND DECLARATION & DIV TARGET '26
26th Jan 20262:30 pmRNSNet Asset Value Weekly to 16 Jan 2026
23rd Jan 20262:10 pmRNSIssue of Equity
22nd Jan 20265:57 pmRNSIssue of Equity
22nd Jan 20263:06 pmRNSJANUARY 2026 SHARE CONVERSION - REPLACEMENT
19th Jan 20264:50 pmRNSIssue of Equity
16th Jan 20265:15 pmRNSNet Asset Value Weekly to 09 Jan 2026
9th Jan 20264:35 pmRNSMARCH 2026 SEMI ANNUAL TENDER RESTRICTIONS
9th Jan 20264:10 pmRNSNet Asset Value Weekly to 02 Jan 2026
9th Jan 20263:06 pmRNSIssue of Equity
8th Jan 20263:57 pmRNSIssue of Equity
7th Jan 202610:20 amRNSNet Asset Value Weekly to 24 Dec 2025
2nd Jan 202611:40 amRNSTotal Voting Rights
31st Dec 20251:00 pmRNSNet Asset Value Weekly to 19 Dec 2025
23rd Dec 20253:37 pmRNSIssue of Equity
23rd Dec 20253:37 pmRNSIssue of Equity
23rd Dec 20252:50 pmRNSPUBLICATION OF NOVEMBER 2025 MONTHLY REPORT
23rd Dec 20252:50 pmRNSPUBLICATION OF NOVEMBER 2025 MONTHLY REPORT
19th Dec 202512:30 pmRNSNet Asset Value Month End 28 Nov 2025
18th Dec 20254:15 pmRNSNet Asset Value Weekly to 12 Dec 2025
18th Dec 202511:01 amRNSJANUARY 2026 SHARE CONVERSION
12th Dec 202512:55 pmRNSNet Asset Value Weekly to 05 Dec 2025
11th Dec 20253:14 pmRNSIssue of Equity
5th Dec 20255:00 pmRNSNet Asset Value Weekly to 28 Nov 2025
5th Dec 20252:52 pmRNSIssue of Equity
3rd Dec 20253:28 pmRNSIssue of Equity
2nd Dec 20254:18 pmRNSIssue of Equity
2nd Dec 202510:06 amRNSPublication of October 2025 Monthly Report
1st Dec 20253:54 pmRNSTotal Voting Rights
28th Nov 202510:15 amRNSNet Asset Value Weekly to 21 Nov 2025
27th Nov 20259:04 amRNSNet Asset Value Month End 31 October 2025
26th Nov 20253:14 pmRNSIssue of Equity
20th Nov 20256:13 pmRNSNet Asset Value Weekly to 14 Nov 2025
17th Nov 20253:31 pmRNSIssue of Equity
14th Nov 20255:22 pmRNSTotal Voting Rights
14th Nov 20254:40 pmRNSNet Asset Value Weekly to 07 Nov 2025
13th Nov 20253:51 pmRNSIssue of Equity
7th Nov 20253:51 pmRNSSEPTEMBER 2025 TENDER - PURCHASE OF SHARES
7th Nov 202511:47 amRNSNet Asset Value Weekly to 31 Oct 2025
5th Nov 20253:45 pmRNSIssue of Equity
4th Nov 20254:24 pmRNSPUBLICATION OF SEPTEMBER 2025 MONTHLY REPORT
3rd Nov 202512:05 pmRNSNet Asset Value Weekly to 24 Oct 2025
3rd Nov 202512:04 pmRNSTotal Voting Rights
30th Oct 20254:43 pmRNSIssue of Equity
29th Oct 202510:37 amRNSDividend Declaration
28th Oct 20254:21 pmRNSSeptember 2025 Tender Price
28th Oct 20254:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.